0001225208-25-002922.txt : 20250304 0001225208-25-002922.hdr.sgml : 20250304 20250304195214 ACCESSION NUMBER: 0001225208-25-002922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250228 FILED AS OF DATE: 20250304 DATE AS OF CHANGE: 20250304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cordani David CENTRAL INDEX KEY: 0001318751 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 25707942 MAIL ADDRESS: STREET 1: THE CIGNA GROUP STREET 2: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 4 1 doc4.xml X0508 4 2025-02-28 0001739940 Cigna Group CI 0001318751 Cordani David 900 COTTAGE GROVE ROAD BLOOMFIELD CT 06002 1 1 Chairman & CEO 1 Common Stock, $.01 Par Value 2025-02-28 4 A 0 49437.0000 0.0000 A 170783.0000 D Common Stock, $.01 Par Value 2025-02-28 4 A 0 11117.0000 0.0000 A 181900.0000 D Common Stock, $.01 Par Value 2025-02-28 4 F 0 4696.0000 305.8600 D 177204.0000 D Common Stock, $.01 Par Value 2025-02-28 4 F 0 22910.0000 305.8600 D 154294.0000 D Common Stock, $.01 Par Value 2025-03-03 4 S 0 26527.0000 308.1200 D 127767.0000 D Common Stock, $.01 Par Value 1757.0080 I By 401(k) Common Stock, $.01 Par Value 334387.0000 I By GRAT Common Stock, $.01 Par Value 153801.0000 I By Trust Employee Stock Option (Right to Buy) 305.8550 2025-02-28 4 A 0 39476.0000 0.0000 A 2026-03-01 2035-02-28 Common Stock, $.01 Par Value 39476.0000 39476.0000 D The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Reflects the transfer by the Reporting Person of 334,387 shares of common stock on May 8, 2024 to the Reporting Person's grantor retained annuity trust. In addition, it reflects the transfer by the Reporting Person's grantor retained annuity trust of 99,918 shares of common stock on January 27, 2025 in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust. These restricted shares vest in three equal annual installments beginning March 1, 2026. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. This option vests in three equal annual installments beginning March 1, 2026. Exhibit List: EX-24 Power of Attorney poacordani.txt Matthew Arnold, attorney-in-fact 2025-03-04 EX-24 2 poacordani.txt POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, a Director and Officer of The Cigna Group, a Delaware corporation ("Cigna"), hereby makes, designates, constitutes and appoints NICOLE S. JONES, KARI KNIGHT STEVENS, ANDREA NELSON, JILL STADELMAN, MATTHEW ARNOLD, ELISE RYAN and TYLER GRATTON, each acting individually, as the undersigned's true and lawful attorneys-in-fact and agents, with full power and authority to act in the undersigned's capacity as a Director and Officer of The Cigna Group for and in the name, place and stead of the undersigned to execute and deliver: (A) in connection with the filing with the Securities and Exchange Commission pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934, both as amended, of: (i) Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under the Securities Act of 1933 and any and all other documents related thereto (including, but not limited to, Seller's Representation Letters) and to take further action as they, or any of them, deem appropriate in connection with the foregoing. Such attorneys-in-fact and agents, or any of them, are also hereby granted full power and authority, on behalf of and in the name, place and stead of the undersigned, to execute and deliver any and all such other documents, and to take further action as they, or any of them, deem appropriate in connection with the foregoing. The powers and authorities granted herein to such attorneys-in-fact and agents, and each of them, also include the full right, power and authority to effect necessary or appropriate substitutions or revocations. The undersigned hereby ratifies, confirms, and adopts, as his or her own act and deed, all action lawfully taken by such attorneys-in-fact and agents, or any of them, or by their respective substitutes, pursuant to the powers and authorities herein granted. This Power of Attorney with respect to Forms 3, 4, 5 and 144 shall remain in full force and effect until:, the undersigned no longer has responsibilities relating to Section 16 of the Securities Exchange Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with respect to the undersigned's beneficial ownership of securities of The Cigna Group, unless earlier revoked by the undersigned in a signed writing to each such attorney in fact. /s/ David Cordani January 6, 2025